Track Pfizer Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Pfizer Inc. PFE.MX · Stock Open Pfizer Inc. in new tab

474.13 MXN
P/E
37.30
EPS
12.71
Yield
6.28%
P/B
1.87
ROE
5.01
Beta
0.28
Loading chart...
Key Metrics
P/E37.30
EPS12.71
Book Value252.91
Price to Book1.87
Debt/Equity74.25
% Insiders0.101%
Growth
Revenue Growth0.03%
Dividend
Dividend Yield6.28%
Annual dividends30.13 MXN
Ex-Div. DateJuly 24, 2026
Payout226.32%
5y avg Yield5.24%

DCF Valuation

Tweak assumptions to recompute fair value for Pfizer Inc. (PFE.MX)
Currency: MXN
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Pfizer Inc. Logo Pfizer Inc. Analysis (PFE.MX)

United States Health Care Official Website Stock

Is Pfizer Inc. a good investment? Pfizer Inc. (PFE.MX) is currently trading at 474.13 MXN.

In terms of valuation, the stock trades at a P/E ratio of 37.30. This high multiple suggests investors have priced in significant future growth expectations.

For income investors, Pfizer Inc. pays a dividend yield of 6.28%. With a payout ratio of 226%, the dividend appears to be under pressure.

Investor FAQ

Does Pfizer Inc. pay a dividend?

Yes, it pays an annual dividend of 30.13 MXN (6.28% yield).

What asset class is Pfizer Inc.?

Pfizer Inc. is classified as a Stock. You can compare it against 12 other assets in the "Related Symbols" list on this page.

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Exchange Ticker
MEX (Mexico) PFE.MX
HAN (Germany) PFE.HA
SGO (Chile) PFE.SN
GER (Germany) PFE.DE
HAM (Germany) PFE.HM
BER (Germany) PFE.BE
STO (Sweden) PFE.ST
VIE (Austria) PFE.VI
STU (Germany) PFE.SG
DUS (Germany) PFE.DU
NYQ (United States) PFE
FRA (Germany) PFE.F
Trades
Dividend Yield
6.28%
5y avg 5.24%
Annual Dividends
30.13MXN
Next Ex. Div Date
July 24, 2026
Payout Ratio
226.32%
Dividend History paid per year (MXN)
Historical Dividends
Year Total Dividends
2027
22.44 MXN
July 23, 2027 (estimated) 7.4798
May 28, 2027 (estimated) 7.4798
Jan. 22, 2027 (estimated) 7.4798
2026
29.36 MXN
Nov. 27, 2026 (estimated) 7.4798
July 24, 2026 7.2950
May 8, 2026 7.2950
Jan. 23, 2026 7.2950
2025
29.18 MXN
Nov. 7, 2025 7.2950
July 25, 2025 7.2950
May 9, 2025 7.2950
Jan. 24, 2025 7.2950
2024
28.50 MXN
Nov. 8, 2024 7.1253
July 26, 2024 7.1253
May 9, 2024 7.1253
Jan. 25, 2024 7.1253
2023
27.82 MXN
Nov. 9, 2023 6.9557
July 27, 2023 6.9557
May 11, 2023 6.9557
Jan. 26, 2023 6.9557
2022
27.14 MXN
Nov. 3, 2022 6.7860
July 28, 2022 6.7860
May 12, 2022 6.7860
Jan. 27, 2022 6.7860
2021
26.47 MXN
Nov. 4, 2021 6.6164
July 29, 2021 6.6164
May 6, 2021 6.6164
Jan. 28, 2021 6.6164
2020
25.79 MXN
Nov. 5, 2020 6.4467
July 30, 2020 6.4467
May 7, 2020 6.4467
Jan. 30, 2020 6.4467
2019
24.43 MXN
Nov. 7, 2019 6.1074
Aug. 1, 2019 6.1074
May 9, 2019 6.1074
Jan. 31, 2019 6.1074
2018
23.07 MXN
Nov. 8, 2018 5.7681
Aug. 2, 2018 5.7681
May 10, 2018 5.7681
Feb. 1, 2018 5.7681
2017
16.29 MXN
Aug. 2, 2017 5.4288
May 10, 2017 5.4288
Feb. 1, 2017 5.4288
2016
20.36 MXN
Nov. 8, 2016 5.0895
Aug. 3, 2016 5.0895
May 11, 2016 5.0895
Feb. 3, 2016 5.0895
2015
19.00 MXN
Nov. 4, 2015 4.7502
Aug. 5, 2015 4.7502
May 6, 2015 4.7502
Feb. 4, 2015 4.7502
2014
17.64 MXN
Nov. 5, 2014 4.4109
July 30, 2014 4.4109
May 7, 2014 4.4109
Feb. 5, 2014 4.4109
2013
16.29 MXN
Nov. 6, 2013 4.0716
July 31, 2013 4.0716
May 8, 2013 4.0716
Jan. 30, 2013 4.0716
2012
14.93 MXN
Nov. 7, 2012 3.7323
Aug. 1, 2012 3.7323
May 9, 2012 3.7323
Feb. 1, 2012 3.7323
2011
13.57 MXN
Nov. 8, 2011 3.3930
Aug. 3, 2011 3.3930
May 11, 2011 3.3930
Feb. 2, 2011 3.3930
2010
12.21 MXN
Nov. 9, 2010 3.0537
Aug. 4, 2010 3.0537
May 5, 2010 3.0537
Feb. 3, 2010 3.0537
2009
31.89 MXN
Nov. 4, 2009 2.7144
Oct. 13, 2009 6.7860
Aug. 5, 2009 2.7144
July 13, 2009 6.7860
May 6, 2009 2.7144
Feb. 13, 2009 4.7502
Feb. 4, 2009 5.4288
2008
38.00 MXN
Nov. 14, 2008 4.0716
Nov. 5, 2008 5.4288
Aug. 18, 2008 4.0716
Aug. 6, 2008 5.4288
May 19, 2008 4.0716
May 7, 2008 5.4288
Feb. 15, 2008 4.0716
Feb. 6, 2008 5.4288
2007
33.25 MXN
Nov. 14, 2007 3.4778
Nov. 7, 2007 4.9199
Aug. 15, 2007 3.4778
Aug. 8, 2007 4.9199
May 16, 2007 3.4778
May 9, 2007 4.9199
Feb. 14, 2007 3.1385
Feb. 7, 2007 4.9199
2006
25.62 MXN
Nov. 15, 2006 2.7144
Nov. 8, 2006 4.0716
Aug. 16, 2006 2.2055
Aug. 9, 2006 4.0716
May 17, 2006 2.2055
May 10, 2006 4.0716
Feb. 15, 2006 2.2055
Feb. 8, 2006 4.0716
2005
20.36 MXN
Nov. 16, 2005 1.8662
Nov. 8, 2005 3.2234
Aug. 17, 2005 1.8662
Aug. 10, 2005 3.2234
May 18, 2005 1.8662
May 11, 2005 3.2234
Feb. 16, 2005 1.8662
Feb. 9, 2005 3.2234
2004
8.65 MXN
Nov. 9, 2004 2.8841
Aug. 11, 2004 2.8841
May 12, 2004 2.8841
Upcoming Dividends
Name Payment Date Status Amount
Pfizer Inc. Jul 24, 2026 7.29495 MXN
Pfizer Inc. May 08, 2026 7.29495 MXN
Pfizer Inc. Jan 23, 2026 7.29495 MXN
Pfizer Inc. Nov 07, 2025 7.29495 MXN
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion